My Take on Niacin
Niacin (vitamin B3) was one of the first drugs used to improve cholesterol levels. It was frequently used with good results before the introduction of statin medications. Now, it is common for conventional medical doctors to tell patients to stop taking niacin and take statins instead. Experts in lipidology and preventive cardiology still use niacin because it works well when combined with a statin.
When the Patient Can Not Tolerate a Statin
Typical statins (lipid-lowering medications) include Crestor (rosuvastatin), Lipitor (atorvastatin), Zocor (simvastatin), Livalo (pitavastatin), Mevacor (lovastatin), and pravastatin (Pravachol). Statins work by blocking an enzyme called HMG-CoA reductase. Unfortunately, this mechanism also blocks the body’s production of coenzyme Q10. Between 5 and 30% of patients are statin intolerant or do not fill their prescriptions. 1The most common symptoms I see are tendinitis, muscle pain, joint pain, elevated blood sugar, and cognitive difficulties. I typically do not see liver enzyme elevations unless the dose is high. Recent studies point to less benefits from statins in the elderly.
In patients who do not tolerate statins well I have had good results with lowering the dose of the statin medication and adding niacin. I sometimes use niacin alone or with several other natural molecules and nutraceuticals.
Limitations of Recent Niacin Trials
Niacin has fallen out of favor with conventional medical doctors. Two negative studies have been published in prominent medical journals since 2011. Both had serious design faults and were funded by the pharmaceutical industry. It is ironic that there was a drug containing simvastatin and niacin that was heavily promoted until the manufacturer stopped making it because it was not profitable enough. This product was called Simcor and it was a great drug with a good track record.2 The pharmaceutical industry does not like niacin now because it reduces sales of statins.
I will tell you why these negative studies had serious faults. The Atherothrombosis Intervention and Metabolic Syndrome with Low HDL and High Triglycerides and Impact on Global Health Outcomes Study (AIM-HIGH) published in 2011 and the Heart Protection Study-2 Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) published in 2014 concluded that adding niacin to a statin did not provide any clinical benefit compared to statin alone. It is as if both trials were designed to make niacin look bad. There are major limitations to these two trials.
AIM-HIGH Trial:
Patients were pretreated with statins, and both cases had baseline LDLs averaging ~72 mg/dL , which is already at target. Yes, that is correct. Their LDLs were already averaging in the low 70s. The biggest changes to risk occur when the patient has high numbers to start with. These patients were not good candidates for niacin.
The “placebo group” received an active placebo (50 g of niacin), and patients in the placebo group ALSO received ezetimibe (Zetia). Zetia is a cholesterol drug. So yes, the placebo group got more treatment, making the group receiving the niacin look worse than it should have.
Subjects were not good candidates for niacin in the first place because they had normal triglycerides, HDL, and LDL. Niacin's main actions are lowering LDL, decreasing triglycerides, and increasing HDL. If the patient just has a high LDL, I typically will not use niacin.
The dose of niacin was much smaller than in previous positive studies (2 g vs 3-4 g)
The placebo group ALSO received a higher mean statin dose.
In my view the study was stopped prematurely (only three years)
HPS2 THRIVE Trial:
In this study sponsored by Merck, the maker of simvastatin, baseline lipids were not high enough (mean LDL ~63 mg/dL) to substantiate the use of niacin. These patients had even lower levels of LDL than the AIM-HIGH study.
Subjects were pretreated with statins. So yes, rather than starting off fresh with a statin and niacin together compared to statin alone or compared to niacin alone, these patients had been rolling along on statins already!
Laropiprant was used with niacin. Laropiprant has actions that counteract the beneficial effects of niacin as well as possible negative cardiovascular side effects independent of niacin.
There was no niacin-only group.
In addition, a disproportionate number of Chinese subjects were included in the study. A genetic predisposition to side effects from niacin with laropiprant may occur in this population.
In both studies, simvastatin was used, there was no niacin monotherapy group, inclusion criteria have been questioned, and positive results occurred in some subgroups that were not discussed. I do not believe firm conclusions about niacin should be made based on these two studies, especially considering their flaws. This is sad when considering niacin has been shown in other studies to be beneficial in reversing plaque, lowering cholesterol, and reducing risk. The Coronary Drug Project (CDP) the Stockholm Trial, CLAS, HATS, ARBITER-2, ARBITER-6, AFREGS all demonstrated improvements in nonfatal heart attack, plaque regression, and incidence of cardiovascular events.
The Benefits of Natural Treatment for High Cholesterol
It is not just the limitations of these two trials that are important to consider. Niacin has other benefits for the vascular system. Niacin can improve endothelial function and make arteries more resilient by decreasing oxidative stress and inflammation. Some people just cannot handle statins or intestinal cholesterol blockers. I am not against cholesterol drugs. I frequently use them along with other treatments in my practice.
What is sad is that in the conventional model, patients who cannot tolerate conventional medications are not treated at all. The exception is when the patient has good insurance and the PCSK 9 inhibitor gets approved. This is an injectable monoclonal antibody that blocks cholesterol production, and it costs between $300.00 and $1,000 per month.
I also think it is important to compare the benefits and risks of niacin to those of a statin drug. The best use of niacin may not be when combined with a statin drug. Niacin is appropriate for statin-intolerant patients, especially those with low HDL, high triglycerides, lipoprotein a, and elevated small LDL lipoprotein particle number.
Side Effects of Niacin for High Cholesterol
The side effects of niacin depend on the dose, but at 1,000 mg and below, they are minimal. The main side effect is increased blood flow to the skin, causing skin flushing. This feeling is like a mild sunburn that lasts for a few minutes. If taken with food, this typically goes away after a few weeks.
At higher doses (<1,500 mg) side effects can include elevated uric acid, increases in homocysteine, increased blood sugar. It is important to do follow-up blood work when on niacin. Side effects can easily be prevented. That is my take on niacin.
Other articles supporting my view:
Superko HR, Zhao XQ, Hodis HN, Guyton JR. Niacin and heart disease prevention: Engraving its tombstone is a mistake. J Clin Lipidol. 2017 Nov-Dec;11(6):1309-1317.
Zeman M, Vecka M, Perlík F, Hromádka R, Staňková B, Tvrzická E, Žák A. Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place? Med Sci Monit. 2015 Jul 25;21:2156-62.
Houston M, Pizzorno J. “Niacin Doesn’t Work and Is Harmful!” Proclaim the Headlines. Yet Another Highly Publicized Questionable Study to Discredit Integrative Medicine. Integr Med (Encinitas). 2014 Oct;13(5):8-11.